Definitive Contract 75A50223C00043
Award Date
9/20/23
Potential Completion Date
3/19/25
Potential Value
$50M
Awardee
Maxim Biomedical, Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Maxim Biomedical, Inc., a self-certified small disadvantaged business and Asian-Pacific American-owned manufacturer of medical devices and diagnostic tests. The $2,700,000.00 firm-fixed-price contract is for the procurement of over-the-counter (OTC) COVID-19 tests. The contract has a completion date of February 24, 2023 and was awarded on...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a firm fixed price purchase order to Maxim Biomedical, Inc., a self-certified small disadvantaged, woman-owned, and Asian-Pacific American-owned business, for the development of lateral flow immunoassays (LFIs). The $251,080.00 contract, which has a Coronavirus COVID-19 national interest action code, is for the delivery of LFIs to support COVID-19 testing efforts across the Department of...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order to Maxim Biomedical, Inc., a small disadvantaged, woman-owned, Asian-Pacific American-owned medical device manufacturing company based in Rockville, Maryland. The $120,150.00 award is for the provision of SWIFT HIV RECENT INFECTION ASSAY (RIA) KITS. This sole source contract was issued under the authority of FAR 13.106-1(b) and 10 U.S.C. 2304(c)(1) due to brand name...
The Department of Health and Human Services (HHS) National Institutes of Health National Heart Lung and Blood Institute awarded a $5,253,450.00 firm fixed-price contract to Maxim Biomedical, Inc. to provide RADX TECH SARS-COV-2 antigen rapid tests. The contract has an estimated completion date of August 27, 2023 and was awarded on August 28, 2020. Maxim Biomedical is a small disadvantaged, woman-owned, Asian-Pacific American owned business that specializes in medical device manufacturing,...
<p>The U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, awarded a $86,400,000.00 Firm Fixed Price definitive contract to Barupon LLC, a woman-owned small business, for the delivery of Over the Counter (OTC) COVID-19 tests. The contract has an ultimate completion date of March 19, 2025 and was awarded on September 20, 2023. No set-aside designation was used for this contract.</p>
The U.S. Department of Health and Human Services, through the Office of the Assistant Secretary for Preparedness and Response, awarded a $26,510,400 firm-fixed-price definitive contract to Atlantic Trading LLC, a woman-owned small business, for the provision of over-the-counter COVID-19 tests. The contract, which has a period of performance through March 4, 2026, does not have a set-aside designation. Atlantic Trading LLC is a provider of medical supplies and personal protective equipment,...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $81,160 firm fixed price purchase order contract to Maxim Biomedical, Inc., a small disadvantaged business, to provide rapid HIV-1 test kits. The contract was a sole source award with no set-aside designation. Maxim Biomedical has provided COVID-19 and other infectious disease test kits to the Department of Health and Human Services and Department of Defense under prior contracts. The award was part of the CDC's efforts to...
The U.S. Department of Health and Human Services, through the Office of the Assistant Secretary for Preparedness and Response, awarded a $61,236,000 firm fixed-price definitive contract to Azure Medical, Inc., a minority-owned small disadvantaged business, for the delivery of over-the-counter (OTC) COVID-19 tests. The contract, which has a period of performance through March 19, 2025, was awarded on September 20, 2023 and does not have a set-aside designation. As a manufacturer of goods, Azure...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $171,085 delivery order to Maxim Biomedical, Inc. of Potomac, Maryland. The firm fixed price order is for the delivery of SARS-COV-2 lateral flow immunoassay kits in support of the Coronavirus COVID-19 national interest. Performance will occur in Potomac through June 2021. No subcontractors or set aside designations were indicated. The order was funded by the Army Acquisition Support...
The U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $46,750,000 firm fixed price contract to Access Bio, Inc. to procure over-the-counter (OTC) COVID-19 tests. The contract has an ultimate completion date of May 26, 2023 and was awarded on March 13, 2023. Access Bio, Inc. is a minority-owned, for-profit, Asian-Pacific American manufacturer of goods. This contract is part of Access Bio's portfolio of federal prime and...